Library

A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.

1 November 2022. doid: 10.1002/mdc3.13563

Thijssen E, Makai-Bölöni S, van Brummelen E, den Heijer J, Yavuz Y, Doll RJ, Groeneveld GJ

View publication

Movement Disorder Society-Unified Parkinson's Rating Scale Part III (MDS-UPDRS III) is the gold standard for assessing medication effects in patients with Parkinson's disease (PD). However, short and rater-independent measurements would be ideal for future trials.

Advancing the boundaries of clinical drug development

Wondering how we can help you? Reach out to us.

Get in contact
contact